CAS 144689-24-7
:Olmésartan
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-
- 1H-Imidazole-5-carboxylicacid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
- Cs 088
- Olmesartan
- Olmetor
- Rnh 6270
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Olmesartan
CAS :Formule :C24H26N6O3Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :446.511-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-4-(2-Hydroxypropan-2-Yl)-2-Propyl-1H-Imidazole-5-Carboxylic Acid
CAS :1-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-4-(2-Hydroxypropan-2-Yl)-2-Propyl-1H-Imidazole-5-Carboxylic AcidFormule :C24H26N6O3Degré de pureté :98%Masse moléculaire :446.5Olmesartan (Olmesartan Medoxomil EP Impurity A)
CAS :Formule :C24H26N6O3Couleur et forme :White To Off-White SolidMasse moléculaire :446.51Olmesartan
CAS :Formule :C29H30N6O6Degré de pureté :(HPLC) ≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :558.594-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (Olmesartan)
CAS :Produit contrôléFormule :C24H26N6O3Couleur et forme :NeatMasse moléculaire :446.54-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid
CAS :Formule :C24H26N6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :446.5016Olmesartan (Standard)
CAS :Olmesartan (Standard) is a reference standard for research and analysis in studies involving Olmesartan. Olmesartan (RNH 6270) is an Angiotensin II Type I receptor antagonist. Olmesartan is the active form of the antihypertensive drug olmesartan medoxomil,and has antihypertensive activity.Formule :C24H26N6O3Masse moléculaire :446.5016Olmesartan 100 µg/mL in Acetonitrile:Methanol
CAS :Produit contrôléFormule :C24H26N6O3Couleur et forme :Single SolutionMasse moléculaire :446.5Olmesartan Acid
CAS :Produit contrôléImpurity Olmesartan EP Impurity A
Applications Olmesartan Acid (Olmesartan EP Impurity A) is an angiotensin II receptor antagonist. Used as an anti-hypertensive.
References Yanagisawa, H., et al.: J. Med. Chem., 39, 323 (1996), Puchler, K., et al.: J. Hypertens., 15, 1809 (1997),Formule :C24H26N6O3Couleur et forme :NeatMasse moléculaire :446.5Olmesartan
CAS :Olmesartan (RNH 6270) is an Angiotensin II Type I receptor antagonist.Formule :C24H26N6O3Degré de pureté :91.89% - 99.81%Couleur et forme :White SolidMasse moléculaire :446.5016Olmesartan
CAS :1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acidFormule :C24H26N6O3Degré de pureté :98%Masse moléculaire :446.5Olmesartan
CAS :Olmesartan medoxomil is a prodrug that is hydrolyzed to olmesartan, its active form. It is a member of the angiotensin II receptor antagonists and it is used for the treatment of hypertension and heart failure. Olmesartan medoxomil reduces the risk of cardiovascular events in patients with resistant hypertension or heart failure. The drug binds to the angiotensin II type 1 receptor, thereby blocking the binding of angiotensin II to this receptor. This prevents activation of downstream signaling pathways, including phospholipase C, protein kinase C, and mitogen-activated protein kinases. Olmesartan medoxomil also blocks the formation of new blood vessels and vascular remodeling in animal models.
Formule :C24H26N6O3Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :446.5 g/molRef: 3D-IH57928
Produit arrêté















